Cardiac metabolomics is a cutting-edge field of study that focuses on the comprehensive analysis of small molecules involved in the metabolic processes within the heart. This discipline plays a crucial role in unraveling the intricate interplay of metabolites, providing valuable insights into the metabolic pathways associated with cardiovascular health and disease. By examining the dynamic changes in metabolite profiles, researchers gain a deeper understanding of the molecular mechanisms underlying cardiac conditions, paving the way for the development of innovative diagnostic tools and targeted therapeutic interventions. Through the lens of metabolomics, scientists aim to decipher the metabolic signatures associated with various cardiac disorders, offering a promising avenue for advancing personalized medicine and enhancing our ability to detect, monitor, and treat cardiovascular diseases with greater precision.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China